国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
9期
1214-1217
,共4页
江涛%李隆玉%吴婷婷%付丹%于晓红%王晨亮%陈小鸽%吴美玲
江濤%李隆玉%吳婷婷%付丹%于曉紅%王晨亮%陳小鴿%吳美玲
강도%리륭옥%오정정%부단%우효홍%왕신량%진소합%오미령
宫颈癌%P14蛋白%P16蛋白%免疫组织化学
宮頸癌%P14蛋白%P16蛋白%免疫組織化學
궁경암%P14단백%P16단백%면역조직화학
Cervical Carcinoma%P14 protein%P16 protein%Immunohistochemistry
目的 探讨P14、P16在宫颈癌组织中的表达及其与临床病理参数的相关性.方法 采用免疫组织化学链霉素抗生素-过氧化酶连接法(S-P法)检测P14、P16在56例宫颈鳞癌组织、20例CIN Ⅲ组织和30例正常宫颈组织中的表达情况.结果 P14和P16蛋白在正常宫颈组织中的阳性表达率明显低于CIN Ⅲ组织和宫颈癌组织,差异有显著性(P<0.05).P14蛋白的表达与浸润深度、病理分级及淋巴转移有关(P<0.05),与临床分期、年龄、肿瘤大小或脉管有无癌栓无关(P>0.05);P16蛋白的表达与病理分级及淋巴转移有关(P< 0.05),与临床分期、年龄、肿瘤大小、浸润深度或脉管有无癌栓无关(P>0.05).结论 P14、P16基因的高表达发生在宫颈癌和癌前病变阶段,对宫颈癌的诊断及预后判断有一定价值,故可作为肿瘤标记物用于宫颈癌的临床筛查及诊断.
目的 探討P14、P16在宮頸癌組織中的錶達及其與臨床病理參數的相關性.方法 採用免疫組織化學鏈黴素抗生素-過氧化酶連接法(S-P法)檢測P14、P16在56例宮頸鱗癌組織、20例CIN Ⅲ組織和30例正常宮頸組織中的錶達情況.結果 P14和P16蛋白在正常宮頸組織中的暘性錶達率明顯低于CIN Ⅲ組織和宮頸癌組織,差異有顯著性(P<0.05).P14蛋白的錶達與浸潤深度、病理分級及淋巴轉移有關(P<0.05),與臨床分期、年齡、腫瘤大小或脈管有無癌栓無關(P>0.05);P16蛋白的錶達與病理分級及淋巴轉移有關(P< 0.05),與臨床分期、年齡、腫瘤大小、浸潤深度或脈管有無癌栓無關(P>0.05).結論 P14、P16基因的高錶達髮生在宮頸癌和癌前病變階段,對宮頸癌的診斷及預後判斷有一定價值,故可作為腫瘤標記物用于宮頸癌的臨床篩查及診斷.
목적 탐토P14、P16재궁경암조직중적표체급기여림상병리삼수적상관성.방법 채용면역조직화학련매소항생소-과양화매련접법(S-P법)검측P14、P16재56례궁경린암조직、20례CIN Ⅲ조직화30례정상궁경조직중적표체정황.결과 P14화P16단백재정상궁경조직중적양성표체솔명현저우CIN Ⅲ조직화궁경암조직,차이유현저성(P<0.05).P14단백적표체여침윤심도、병리분급급림파전이유관(P<0.05),여림상분기、년령、종류대소혹맥관유무암전무관(P>0.05);P16단백적표체여병리분급급림파전이유관(P< 0.05),여림상분기、년령、종류대소、침윤심도혹맥관유무암전무관(P>0.05).결론 P14、P16기인적고표체발생재궁경암화암전병변계단,대궁경암적진단급예후판단유일정개치,고가작위종류표기물용우궁경암적림상사사급진단.
Objective To explore the expressions of P14 and P16 in cervical carcinoma tissue and its relationship with clinical pathological-parameters.Methods Expressions of P14 protein and P16 in 56 cases' squamous cervical arcinoma tissue,20 cases' CIN Ⅲ tissue and 30 cases' normal cervical tissue were detected with S-P immunochemistry technology.Results The positive expression rates of P14 and P16 proteins were significantly lower in normal cervical tissue than in the CIN Ⅲ and squamous cervical carcinoma( P< 0.05 ).The expression of P14 in squamous cervical carcinoma related to tumor infiltrate deepness,pathological stage and lymph node metastasis ( P < 0.05 ) but not related to clinical stage,age,tumor size and cancer embolus( P> 0.05 ).The expression of P16 in squamous cervical carcinoma related to pathological stage and lymph node metastasis ( P < 0.05 ) but not related to clinical stage,age,tumor size, tumor infiltrate deepness and cancer embolus ( P > 0.05 ).Conclusions P14 and P16 expess highly in CIN and cervical carcinoma,which has value in the diagnosis and prognostic valuation of cervical carcinoma.Consequently,both of them can be used as biomarkers for the screening and diagnosis of cervical carcinoma.